Xilio Therapeutics
XLO
#9732
Rank
โ‚ฌ31.25 M
Marketcap
0,60ย โ‚ฌ
Share price
-1.90%
Change (1 day)
-55.52%
Change (1 year)

EPS for Xilio Therapeutics (XLO)

EPS in 2023 (TTM): -2,90ย โ‚ฌ

According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -2,81ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,94ย โ‚ฌ a decrease over its 2021 EPS that were of -2,82ย โ‚ฌ.

EPS history for Xilio Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,90ย โ‚ฌ-1.44%
2022-2,94ย โ‚ฌ4.42%
2021-2,82ย โ‚ฌ